Developing a Standardised National Model of Care for Treatment of Peanut Allergy in Infants: The ADAPT Peanut Oral Immunotherapy Program

Abstract

Introduction: Peanut allergy is the most common food allergy in Australian school-aged children and is rarely outgrown. Access to oral immunotherapy (OIT), a disease-modifying treatment for food allergy, is limited in many regions of the world, including Australia. Clinical trials show high rates of allergic desensitisation and remission are being achieved, particularly in young children, but significant variability in protocols and implementation prevents large-scale evaluation of clinical and patient-reported safety, effectiveness and long-term outcomes. A standardised national model of care OIT program has not been previously attempted. In Australia, the National Allergy Centre of Excelle..